Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to week 54

QR Code

Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to week 54

Objective To investigate the efficacy, safety and immunogenicity of PF-06438179/GP1111 (PF-SZ-IFX) compared with European reference infliximab (Remicade®; ref-IFX) in patients with moderate-to-severe, active rheumatoid arthritis after continued long-term use of PF-SZ-IFX, and in patients who were sw...

Fuld beskrivelse

Saved in:

Bibliografiske detaljer
Main Authors:	Goran Babic, Hideto Kameda, Rieke Alten, Bogdan Batko, Tomas Hala, Sebastiao C Radominski, Vira Tseluyko, Carol Cronenberger, Sarah Hackley, Muhammad Rehman, Oliver von Richter, Min Zhang, Stanley Cohen
Format:	Article
Sprog:	engelsk
Udgivet:	BMJ Publishing Group 2019-05-01
Serier:	RMD Open
Online adgang:	https://rmdopen.bmj.com/content/5/1/e000876.full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!

Lignende værker

Therapy for psoriatic arthritis with infliximab
af: V V Badokin, et al.
Udgivet: (2009-03-01)

Infliximab in Russian clinical practice
af: G V Lukina, et al.
Udgivet: (2012-09-01)

Infliximab in the therapy of rheumatoid arthritis
af: G. V. Lukina, et al.
Udgivet: (2016-05-01)

INFLIXIMAB IN TREATMENT OF ACTIVE JUVENILE ARTHRITIS
af: E. S. Zholobova, et al.
Udgivet: (2012-05-01)

INFLIXIMAB IN TREATMENT OF REFRACTORY JUVENILE ARTHRITIS
af: I.P. Nikishina, et al.
Udgivet: (2010-01-01)

INFLIXIMAB (REMICADE): POSSIBILITIES IN THE TREATMENT OF RHEUMATOID ARTHRITIS
af: Nataliya Vladimirovna Chichasova, et al.
Udgivet: (2011-03-01)

Infliximab Therapy for Plaque Psoriasis: The UCL Experience
af: Ghislain, Pierre-Dominique
Udgivet: (2012)

EFFECTIVENESS OF INFLIXIMAB IN PATIENTS WITH JUVENILE ANKYLOSING SPONDYLARTHRITIS
af: A.L. Kozlova, et al.
Udgivet: (2009-03-01)

EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)EFFICACY OF INFLIXIMAB IN THERAPY OF REFRACTORY JUVENILE RHEUMATOID ARTHRITIS (JRA)
af: E.I. Alexeeva, et al.
Udgivet: (2006-03-01)

THE EXPERIENCE OF INFLIXIMAB USAGE IN JUVENILE ARTHRITIS IN THE REPUBLIC OF BASHKORTOSTAN
af: V. A. Malievskii, et al.
Udgivet: (2012-11-01)

USE OF INFLIXIMAB IN THE CASE OF INFLAMMATORY BOWEL DISEASE IN CHILDREN
af: N.E. Shchigoleva, et al.
Udgivet: (2010-02-01)

Comparative efficacy of infliximab and adalimumab in patients with ankylosing spondylitis
af: Tatyana Valentinovna Mezenova, et al.
Udgivet: (2012-04-01)

TREATMENT WITH INFLIXIMAB IN PATIENT WITH EARLY POLYARTICULAR JUVENILE RHEUMATOID ARTHRITIS
af: T.V. Sleptsova, et al.
Udgivet: (2010-09-01)

EFFECTIVENESS OF INFLIXIMAB IN PATIENT WITH SYSTEMIC TYPE OF JUVENILE RHEUMATOID ARTHRITIS
af: E.S. Zholobova, et al.
Udgivet: (2011-03-01)

INFLIXIMAB: HAVE ALL QUESTIONS BEEN ANSWERED FOR 10 YEARS?
af: R M Balabanova, et al.
Udgivet: (2010-03-01)

Predictors of infliximab efficacy in patients with severe attack of ulcerative colitis
af: A. O. Golovenko, et al.
Udgivet: (2013-10-01)

INVESTIGATION OF A ROLE OF THE IMMUNOGENICITY OF INFLIXIMAB IN THE THERAPY OF ANKYLOSING SPONDYLITIS
af: O. A. Rumyantseva, et al.
Udgivet: (2016-09-01)

Infliximab tolerance in patients with rheumatoid arthritis in real clinical practice
af: E. S. Aronova, et al.
Udgivet: (2020-02-01)

New possibilities of infliximab administration in chronic inflammatory rheumatic diseases
af: A. I. Dubikov, et al.
Udgivet: (2005-04-01)

Experience with long-term infliximab therapy in patients with ankylosing spondylitis
af: Oksana Alekseevna Rumyantseva, et al.
Udgivet: (2010-12-01)

To combat with multifaceted cachectin (experience with infliximab used for unregistered indications
af: Dmitry Evgenyevich Karateyev, et al.
Udgivet: (2011-06-01)

QUALITY OF LIFE IN CHILDREN WITH JUVENILE RHEUMATOID ARTHRITIS TREATED WITH INFLIXIMAB
af: R.V. Denisova, et al.
Udgivet: (2008-12-01)

EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY JUVENILE RHEUMATOID ARTHRITIS
af: E.I. Alexeeva, et al.
Udgivet: (2009-07-01)

How We Can Personalize the Infliximab Use in Ulcerative Patients
af: Mohammed Hussien Ahmed, et al.
Udgivet: (2025-06-01)

Clinical Profile of Ankylosing Spondylitis and Outcome of Patients Treated with Infliximab
af: Dipankar Pal, et al.
Udgivet: (2025-04-01)

EFFICACY OF INFLIXIMAB IN PATIENT WITH UNFAVORABLE CLINICAL COURSE OF JUVENILE RHEUMATOID ARTHRITIS
af: L.A. Balykova, et al.
Udgivet: (2011-05-01)

EFFICACY OF INFLIXIMAB IN RHEUMATOID ARTHRITIS: A RELATIONSHIP TO THE TOTAL DOSE OF THE DRUG
af: E. S. Aronova, et al.
Udgivet: (2015-10-01)

EFFECTIVENESS AND SAFETY OF INFLIXIMAB IN PATIENTS WITH EARLY AND LATE JUVENILE RHEUMATOID ARTHRITIS
af: Е.I. Alexeeva, et al.
Udgivet: (2010-05-01)

FITV 1111: Anime Goes to College Syllabus
af: Emilie Waggoner
Udgivet: (2024-12-01)

EXPERIENCE OF TREATMENT WITH ABATACEPT IN CHILD WITH JUVENILE RHEUMATOID ARTHRITIS AND SECONDARY INEFFICIENCY OF INFLIXIMAB
af: I.P. Nikishina, et al.
Udgivet: (2011-05-01)

PRACTICE OF INFLIXIMAB TREATMENT OF A PATIENT WITH SEVERE POLIARTICULAR JUVENILE RHEUMATOID ARTHRITIS
af: T.V. Sleptsova, et al.
Udgivet: (2011-09-01)

CONTINUOUS INFLIXIMAB THERAPY FOR A 14-YEARS-OLD GIRL WITH CROHN DISEASE
af: E.N. Fedulova, et al.
Udgivet: (2009-08-01)

Russian registry of Infliximab.Impact of therapy on the functional status of patients with rheumatoid arthritis
af: V N Amirdzhanova, et al.
Udgivet: (2010-12-01)

DYNAMICS OF CYTOKINE PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS AS INFLUENCED BY INFLIXIMAB (REMIKEID) ADMINISTRATION
af: E. S. Zhugrova, et al.
Udgivet: (2014-07-01)

Comparative efficacy and safety of infliximab biosimilar (BCD-055) and innovator infliximab in patients with ankylosing spondylitis (results of international, multiple-center, double-blind phase I and phase III clinical studies)
af: D. E. Karateev, et al.
Udgivet: (2017-09-01)

INFLIXIMAB EFFECT ON CLINICAL AND LABORATORY ACTIVITY PARAMETERS IN CASES OF VARIOUS JUVENILE ARTHRITIS VARIANTS
af: E.I. Alexeeva, et al.
Udgivet: (2008-04-01)

Eurasian Tax Week
af: V. V. Dvoretskaya, et al.
Udgivet: (2021-07-01)

COMPARATIVE EVALUATION OF THE LONG-TERM EFFICACY AND SAFETY OF THE INFLIXIMAB BIOSIMILAR BCD-055 AND REFERENCE INFLIXIMAB IN PATIENTS WITH ANKYLOSING SPONDYLITIS: RESULTS OF THE INTERNATIONAL MULTICENTER RANDOMIZED DOUBLE-BLIND PHASE III CLINICAL STUDY ASART-2
af: A. M. Lila, et al.
Udgivet: (2018-07-01)

Efficacy of netakimab in key psoriatic arthritis domains: 54-week results from the phase III BCD-085-8/PATERA study
af: T. V. Korotaeva, et al.
Udgivet: (2021-03-01)

DYNAMICS OF CARDIOVASCULAR STATUS AND SERUM MARKERS OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS, TREATED WITH INFLIXIMAB
af: S. P. Oranskyi, et al.
Udgivet: (2013-04-01)